240 related articles for article (PubMed ID: 29573043)
1. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease.
Antonellis A; Oprescu SN; Griffin LB; Heider A; Amalfitano A; Innis JW
Hum Mutat; 2018 Jun; 39(6):834-840. PubMed ID: 29573043
[TBL] [Abstract][Full Text] [Related]
2. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease.
Zadjali F; Al-Yahyaee A; Al-Nabhani M; Al-Mubaihsi S; Gujjar A; Raniga S; Al-Maawali A
Hum Mutat; 2018 Oct; 39(10):1355-1359. PubMed ID: 30014610
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanyl-tRNA synthetase deficiency caused by biallelic variants in FARSA gene and literature review.
Guo R; Chen Y; Hu X; Qi Z; Guo J; Li Y; Hao C
BMC Med Genomics; 2023 Oct; 16(1):245. PubMed ID: 37833669
[TBL] [Abstract][Full Text] [Related]
4. FARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects.
Krenke K; Szczałuba K; Bielecka T; Rydzanicz M; Lange J; Koppolu A; Płoski R
Clin Genet; 2019 Nov; 96(5):468-472. PubMed ID: 31355908
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
[TBL] [Abstract][Full Text] [Related]
6. FARS1-related disorders caused by bi-allelic mutations in cytosolic phenylalanyl-tRNA synthetase genes: Look beyond the lungs!
Schuch LA; Forstner M; Rapp CK; Li Y; Smith DEC; Mendes MI; Delhommel F; Sattler M; Emiralioğlu N; Taskiran EZ; Orhan D; Kiper N; Rohlfs M; Jeske T; Hastreiter M; Gerstlauer M; Torrent-Vernetta A; Moreno-Galdó A; Kammer B; Brasch F; Reu-Hofer S; Griese M
Clin Genet; 2021 Jun; 99(6):789-801. PubMed ID: 33598926
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
[TBL] [Abstract][Full Text] [Related]
8. Fatal systemic disorder caused by biallelic variants in FARSA.
Kim SY; Ko S; Kang H; Kim MJ; Moon J; Lim BC; Kim KJ; Choi M; Choi HJ; Chae JH
Orphanet J Rare Dis; 2022 Aug; 17(1):306. PubMed ID: 35918773
[TBL] [Abstract][Full Text] [Related]
9. Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.
Oprescu SN; Griffin LB; Beg AA; Antonellis A
Methods; 2017 Jan; 113():139-151. PubMed ID: 27876679
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammatory syndrome in children with FARSA deficiency.
Charbit-Henrion F; Goguyer-Deschaumes R; Borensztajn K; Mirande M; Berthelet J; Rodrigues-Lima F; Khiat A; Frémond ML; Bader-Meunier B; Rodari MM; Seabra L; Rice GI; Legendre M; Drummond D; Berteloot L; Roux CJ; Boddaert N; Drabent P; Molina TJ; Lacaille F; Kossorotoff M; Cerf-Bensussan N; Parlato M; Hadchouel A
Clin Genet; 2022 May; 101(5-6):552-558. PubMed ID: 35132614
[TBL] [Abstract][Full Text] [Related]
11. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.
Meyer-Schuman R; Antonellis A
Hum Mol Genet; 2017 Oct; 26(R2):R114-R127. PubMed ID: 28633377
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitously Expressed Proteins and Restricted Phenotypes: Exploring Cell-Specific Sensitivities to Impaired tRNA Charging.
Kuo ME; Antonellis A
Trends Genet; 2020 Feb; 36(2):105-117. PubMed ID: 31839378
[TBL] [Abstract][Full Text] [Related]
13. Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.
Gao X; Guo R; Li Y; Kang G; Wu Y; Cheng J; Jia J; Wang W; Li Z; Wang A; Xu H; Jia Y; Li Y; Qi X; Wei Z; Wei C
J Gastroenterol Hepatol; 2021 Nov; 36(11):3113-3126. PubMed ID: 34159625
[TBL] [Abstract][Full Text] [Related]
14. Regulation of E.coli phenylalanyl-tRNA synthetase operon in vivo.
Trudel M; Springer M; Graffe M; Fayat G; Blanquet S; Grunberg-Manago M
Biochim Biophys Acta; 1984 May; 782(1):10-7. PubMed ID: 6426518
[TBL] [Abstract][Full Text] [Related]
15. Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support Non-translational Function.
Xu Z; Lo WS; Beck DB; Schuch LA; Oláhová M; Kopajtich R; Chong YE; Alston CL; Seidl E; Zhai L; Lau CF; Timchak D; LeDuc CA; Borczuk AC; Teich AF; Juusola J; Sofeso C; Müller C; Pierre G; Hilliard T; Turnpenny PD; Wagner M; Kappler M; Brasch F; Bouffard JP; Nangle LA; Yang XL; Zhang M; Taylor RW; Prokisch H; Griese M; Chung WK; Schimmel P
Am J Hum Genet; 2018 Jul; 103(1):100-114. PubMed ID: 29979980
[TBL] [Abstract][Full Text] [Related]
16. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Manole A; Efthymiou S; O'Connor E; Mendes MI; Jennings M; Maroofian R; Davagnanam I; Mankad K; Lopez MR; Salpietro V; Harripaul R; Badalato L; Walia J; Francklyn CS; Athanasiou-Fragkouli A; Sullivan R; Desai S; Baranano K; Zafar F; Rana N; Ilyas M; Horga A; Kara M; Mattioli F; Goldenberg A; Griffin H; Piton A; Henderson LB; Kara B; Aslanger AD; Raaphorst J; Pfundt R; Portier R; Shinawi M; Kirby A; Christensen KM; Wang L; Rosti RO; Paracha SA; Sarwar MT; Jenkins D; ; Ahmed J; Santoni FA; Ranza E; Iwaszkiewicz J; Cytrynbaum C; Weksberg R; Wentzensen IM; Guillen Sacoto MJ; Si Y; Telegrafi A; Andrews MV; Baldridge D; Gabriel H; Mohr J; Oehl-Jaschkowitz B; Debard S; Senger B; Fischer F; van Ravenwaaij C; Fock AJM; Stevens SJC; Bähler J; Nasar A; Mantovani JF; Manzur A; Sarkozy A; Smith DEC; Salomons GS; Ahmed ZM; Riazuddin S; Riazuddin S; Usmani MA; Seibt A; Ansar M; Antonarakis SE; Vincent JB; Ayub M; Grimmel M; Jelsig AM; Hjortshøj TD; Karstensen HG; Hummel M; Haack TB; Jamshidi Y; Distelmaier F; Horvath R; Gleeson JG; Becker H; Mandel JL; Koolen DA; Houlden H
Am J Hum Genet; 2020 Aug; 107(2):311-324. PubMed ID: 32738225
[TBL] [Abstract][Full Text] [Related]
17. FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance.
Almannai M; Wang J; Dai H; El-Hattab AW; Faqeih EA; Saleh MA; Al Asmari A; Alwadei AH; Aljadhai YI; AlHashem A; Tabarki B; Lines MA; Grange DK; Benini R; Alsaman AS; Mahmoud A; Katsonis P; Lichtarge O; Wong LC
Mol Genet Metab; 2018 Nov; 125(3):281-291. PubMed ID: 30177229
[TBL] [Abstract][Full Text] [Related]
18. To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.
Wallen RC; Antonellis A
Curr Opin Genet Dev; 2013 Jun; 23(3):302-9. PubMed ID: 23465884
[TBL] [Abstract][Full Text] [Related]
19. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations.
Meyer-Schuman R; Marte S; Smith TJ; Feely SME; Kennerson M; Nicholson G; Shy ME; Koutmou KS; Antonellis A
Hum Mol Genet; 2023 Jun; 32(13):2177-2191. PubMed ID: 37010095
[TBL] [Abstract][Full Text] [Related]
20. Bacillus subtilis phenylalanyl-tRNA synthetase genes: cloning and expression in Escherichia coli and B. subtilis.
Brakhage AA; Putzer H; Shazand K; Röschenthaler RJ; Grunberg-Manago M
J Bacteriol; 1989 Feb; 171(2):1228-32. PubMed ID: 2492510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
